Galway-based Aerogen is set to add over 700 roles across Galway and Shannon in a major expansion that positions the company for its next growth chapter. Already a global leader in aerosol drug delivery, the medtech innovator is now branching into biopharmaceuticals—broadening its portfolio and accelerating scale.

Recognised as Company of the Month by Business & Finance and KPMG, Aerogen’s expansion underscores the strategic value of homegrown innovation and deep sectoral expertise. With operations in 28 countries and exports fuelling a €30 billion contribution to the economy, Aerogen is proving that Irish companies can compete—and lead—on a global stage.

Read the full article to see how Aerogen is redefining what’s next for medtech.